Serotonin denervation enhances responsiveness of presynaptic dopamine efflux to acute clozapine in nucleus accumbens but not in caudate-putamen

[1]  M. Galloway,et al.  Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. , 1991, European journal of pharmacology.

[2]  C. Ashby,et al.  The effect of typical and atypical antipsychotic drugs on the stimulation of phosphoinositide hydrolysis produced by the 5-HT3 receptor agonist 2-methyl-serotonin , 1991, Brain Research.

[3]  J. Schipper,et al.  Postsynaptic 5-HT1 receptors and offensive aggression in rats: A combined behavioural and autoradiographic study with eltoprazine , 1991, Pharmacology Biochemistry and Behavior.

[4]  E. Gardner,et al.  Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate-putamen as measured by in vivo brain microdialysis: Further evidence for depolarization block , 1991, Neuroscience Letters.

[5]  F. Colpaert,et al.  Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites. , 1990, European journal of pharmacology.

[6]  M. Hamon,et al.  Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells. , 1990, Biochemical pharmacology.

[7]  E. sanders-Bush.  Adaptive regulation of central serotonin receptors linked to phosphoinositide hydrolysis. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[8]  H. Meltzer.  Presynaptic Receptors a Relevance to Psychotropic Drug Action in Man , 1990, Annals of the New York Academy of Sciences.

[9]  N. Newberry,et al.  Interaction of the atypical neuroleptic clozapine with 5-HT3 receptors in the cerebral cortex and superior cervical ganglion of the rat. , 1990, European journal of pharmacology.

[10]  R. Kasser,et al.  The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study , 1990, Brain Research.

[11]  P. Butler,et al.  Regional central serotonin-2 receptor binding and phosphoinositide turnover in rats with 5,7-dihydroxytryptamine lesions , 1990, Brain Research Bulletin.

[12]  C. Ashby,et al.  Effects of antipsychotic drugs on 5-HT2 receptors in the medial prefrontal cortex: microiontophoretic studies , 1990, Brain Research.

[13]  J. Green,et al.  Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum. , 1989, The Journal of pharmacology and experimental therapeutics.

[14]  L. Ereshefsky,et al.  Clozapine: an atypical antipsychotic agent. , 1989, Clinical pharmacy.

[15]  E. Gardner,et al.  Anatomically Selective Action of Atypical Neuroleptics on the Mesocorticolimbic Dopamine System , 1988 .

[16]  G Honigfeld,et al.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. , 1988, Archives of general psychiatry.

[17]  S. Chaki,et al.  5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices. , 1988, European journal of pharmacology.

[18]  J. Palacios,et al.  Localisation by autoradiography of neuronal 5-HT3 receptors in the mouse CNS. , 1988, European journal of pharmacology.

[19]  K. Drescher,et al.  Influence of antipsychotics and serotonin antagonists on presynaptic receptors modulating the release of serotonin in synaptosomes of the nucleus accumbens of rats , 1988, Neuropharmacology.

[20]  A. Beaudet,et al.  Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons , 1987, Brain Research.

[21]  C. Fischette,et al.  Effects of 5, 7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography , 1987, Brain Research.

[22]  S. Algeri,et al.  Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences , 1987, Brain Research.

[23]  J. Palacios,et al.  Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors , 1987, Neuroscience.

[24]  K. Drescher,et al.  Influence of antipsychotics on presynaptic receptors modulating the release of dopamine in synaptosomes of the nucleus accumbens of rats , 1986, Neuropharmacology.

[25]  G. Wenk,et al.  [3H]Ketanserin (Serotonin Type 2) Binding Increases in Rat Cortex Following Basal Forebrain Lesions with Ibotenic Acid , 1986, Journal of neurochemistry.

[26]  C. Finch,et al.  Regional serotonin receptor studies: chronic methysergide treatment induces a selective and dose-dependent decrease in serotonin-2 receptors in mouse cerebral cortex. , 1986, Life sciences.

[27]  C. Altar,et al.  Typical and atypical antipsychotic occupancy of D2 and S2 receptors: An autoradiographic analysis in rat brain , 1986, Brain Research Bulletin.

[28]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.

[29]  D. X. Freedman,et al.  Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain. , 1985, European journal of pharmacology.

[30]  T. Sharp,et al.  Changes in monoamine metabolites measured by simultaneousin vivo differential pulse voltammetry and intracerebral dialysis , 1984, Neuroscience.

[31]  M. Chesselet,et al.  Presynaptic regulation of neurotransmitter release in the brain: Facts and hypothesis , 1984, Neuroscience.

[32]  F. J. White,et al.  Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. , 1983, Science.

[33]  B. Bunney,et al.  Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  T. Westfall,et al.  Inhibition of the electrically induced release of [3H]dopamine by serotonin from superfused rat striatal slices , 1982, Neuroscience Letters.

[35]  B. Cox,et al.  Characterisation of Inhibitory 5‐Hydroxytryptamine Receptors That Modulate Dopamine Release in the Striatum , 1981, Journal of neurochemistry.

[36]  H. Bradford,et al.  Presynaptic Control of the Synthesis and Release of Dopamine from Striatal Synaptosomes: A Comparison Between the Effects of 5‐Hydroxytryptamine, Acetylcholine, and Glutamate , 1980, Journal of neurochemistry.

[37]  R. Adams,et al.  Dopamine release in N. accumbens and striatum by clozapine: Simultaneous monitoring by in vivo electrochemistry , 1980, Neuropharmacology.

[38]  T. Hattori,et al.  Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: A fluorescent retrograde double labeling study in the rat , 1980, Brain Research.

[39]  J. Stevens.  Schizophrenia and dopamine regulation in the mesolimbic system , 1979, Trends in Neurosciences.

[40]  E. Gardner,et al.  Denervation supersensitivity in the mesolimbic system: involvement of dopamine-stimulated adenylate cyclase , 1979, Brain Research.

[41]  L. Thal,et al.  Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes , 1979, Brain Research.

[42]  E. Azmitia,et al.  An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat , 1978, The Journal of comparative neurology.

[43]  S. Snyder,et al.  Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. , 1977, Science.

[44]  M. Geyer,et al.  Histologic and enzymatic studies of the mesolimbic and mesostriatal serotonergic pathways , 1976, Brain Research.

[45]  H. Baumgarten,et al.  5,7‐Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine , 1975, Journal of neurochemistry.

[46]  H. Meltzer,et al.  The mechanism of action of novel antipsychotic drugs. , 1991, Schizophrenia bulletin.

[47]  S. Peroutka.  5-Hydroxytryptamine receptor subtypes. , 1990, Pharmacology & toxicology.

[48]  H. Meltzer,et al.  The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. , 1989, Psychopharmacology bulletin.

[49]  B. Hoebel,et al.  Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. , 1988, Life sciences.

[50]  J. Leysen,et al.  Receptor interactions of dopamine and serotonin antagonists: binding in vitro and in vivo and receptor regulation. , 1988, Psychopharmacology series.

[51]  C. Dourish,et al.  Pustative anxiolytics 8-OH-DPAT, buspirone and TVX Q 7821 are agonists at 5-HT1A autoreceptors in the raphé nuclei , 1986 .

[52]  R. Baldessarini.  Chemotherapy in psychiatry : principles and practice , 1985 .

[53]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[54]  I. Creese,et al.  Chronic neuroleptic treatment and dopamine receptor regulation. , 1980, Advances in biochemical psychopharmacology.